Blog

Research!America is dedicated to ensuring a strong public and private sector investment in research to improve health at a level warranted by scientific opportunity and supported by public opinion. Each blog post aims to inform readers about the health and economic benefits of research.  

Recent Blog Posts

U.S. investments in medical and health research and development (R&D) grew by 13.3% over a three year period (2013 – 2015), according to Research!America’s new investment report . However, medical and health R&D represents a small fraction of total spending on health. Currently, the U.S. spends less than 5 cents of every health dollar on R&D to prevent, treat, and cure disease. More than half of Americans (56%) say that is not enough, a recent public opinion survey shows. Industry, including pharmaceutical, medical technolo­gy, biotechnology and health IT companies, invests more in R&D than other sectors. In 2015, industry invested 64.7% of total spending, followed by the...
Founded in 1977, the American Pain Society (APS) is a multidisciplinary organization of basic and clinical scientists, practicing clinicians, policy analysts and others who conduct pain research, treat pain and advocate for individuals with pain. The mission of APS is to advance pain-related research, education, treatment and professional practice. In 2010, after a decade of APS advocacy efforts to address pain as a national issue, the National Institutes of Health (NIH) contracted with the Institute of Medicine (IOM) to undertake a study and make recommendations “to increase the recognition of pain as a significant public health problem in the United States.” According to their landmark...
The American Association for Cancer Research (AACR) has released the annual Cancer Progress Report , highlighting advances in cancer research, as well as advocating for sustained and robust funding for federal health agencies. AACR also hosted a congressional briefing on the progress report on Wednesday, September 21 to bring to Congress’ attention the importance of funding for research and emphasized patient involvement in moving research forward. Patient participation in clinical trials is important not only to test the efficacy of cancer drugs, but also to further the precision medicine initiative that aims to individualize cancer treatment based on each patient’s genetic code and...
Dear Research Advocate: While Senate leadership had originally planned to pass a continuing resolution (CR) this week and leave town, negotiations are ongoing. Odds still are that a short-term CR providing $1.1 billion in emergency Zika funding will be signed into law before the 9/30/16 deadline. We’ll keep you posted. The 21st Century Cures Initiative (Cures) is on hold once again. Earlier today, House Energy and Commerce Committee Chairman Fred Upton’s (R-MI-06) staff reported progress on a compromise bill crafted to pass both houses of Congress this year, but said it will not be considered until after the elections. Cures advocacy may have a “rock of Sisyphus” feel to it, but there’s...
Hillary Clinton has been clear about her support for vaccines, but Donald Trump appears to be revising his views on immunizations. While supporting vaccination laws established by the states, Gary Johnson thinks the federal government should be allowed to intervene if there is a national or regional health concern. Jill Stein is concerned about declining vaccinations rates and has a plan to reverse it. The presidential candidates’ thoughts on vaccinations and 19 other science-related questions were released last Tuesday by ScienceDebate.org. Trump suggested a year ago at a GOP debate there’s a link between vaccinations and autism, giving an example of a 2 ½ year old child who developed a...
Cancer researchers hope support for the Cancer Moonshot will speed the pace of discovery of life-saving technologies. Speakers at a Capitol Hill briefing held Thursday, September 15, agreed that the moonshot could heighten awareness of the importance of sustained federal funding for cancer research. The briefing, hosted by the American Institute for Medical and Biological Engineering, focused on advances in cancer research that hope to someday replace current treatments such as radiation and chemotherapy. As a result of current therapies, cancer has on average seen a decline in incidence and mortality. However, this is not true of all cancers, said Dr. Krishna Kandarpa, director of research...
Across the United States, hundreds of thousands of researchers are working to better understand a wide range of diseases and conditions, from cancer to heart disease, to rare disorders to Alzheimer disease, and countless others, in order to improve the health and well-being of people in every corner of America and the world. The lifeblood for the majority of these researchers is federal funding received through the National Institutes of Health (NIH). Through more than 57,000 research and training grants, NIH directly supports approximately 300,000 researchers at more than 2,500 universities and organizations located in all 50 states. This funding, in turn, supports local economies and...
Dear Research Advocate: First, it is not too late to sign up for our webinar, The Microbiome Initiative: A Closer Look , which will take place tomorrow , September 16, from 1:00 to 1:30 ET. I am not surprised that interest is strong in this program, which features Dr. Stefano Bertuzzi, CEO of the American Society for Microbiology. Please join us! I was in New York following the birth of my grandson (Ferdinand, 8 pounds, 14 ounces!) and missed our National Health Research Forum last week; however, I watched the video and the panel discussions were absolutely terrific! From the need for a standing public health emergency fund that grounds threat response in pragmatism rather than politics, to...
Watch the videos from each panel, read the transcript , view the photo gallery and read the WebMD live recap . “The biomedical research enterprise underpins the health of the nation and much of the world, and is in dire need of substantial infusion to meet the great medical needs of our time,” said William N. Hait, M.D., Ph.D. , global head, Janssen Research & Development. Hait, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, the keynote speaker at the 2016 National Health Research Forum, added that we’re losing time in addressing threats like the Zika virus, Ebola and cancer while waiting for funding to improve for biomedical research. The program, held...
Dear Research Advocate: I am sending my letter out early this week to ensure you can tune into our National Health Research Forum, Straight Talk: New Thinking on Tough Challenges , which will take place tomorrow at 11:45 a.m. ET at the Newseum in Washington, DC. Our expert moderators will press panelists -- top federal officials and other key leaders from across the research ecosystem -- on critical, complex and in some cases, controversial topics in health, research and innovation. It is sure to be a riveting discussion not to be missed. While the Forum is sold out, you can watch virtually with our event live-stream hosted by WebMD. With Congress returning from recess and the end of fiscal...

Pages

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America